177 related articles for article (PubMed ID: 2526794)
1. Complications of corticosteroid and immunosuppressive drugs.
Rubin B; Palestine AG
Int Ophthalmol Clin; 1989; 29(3):159-71. PubMed ID: 2526794
[No Abstract] [Full Text] [Related]
2. Endocrine complications of topical and intralesional corticosteroid therapy.
Curtis JA; Cormode E; Laski B; Toole J; Howard N
Arch Dis Child; 1982 Mar; 57(3):204-7. PubMed ID: 6462114
[TBL] [Abstract][Full Text] [Related]
3. Overview of the side effects of corticosteroid therapy.
Ansell BM
Clin Exp Rheumatol; 1991; 9 Suppl 6():19-20. PubMed ID: 2060172
[No Abstract] [Full Text] [Related]
4. Uses, adverse effects of abuse of corticosteroids. Part II.
Imam AP; Halpern GM
Allergol Immunopathol (Madr); 1995; 23(1):2-15. PubMed ID: 7631589
[No Abstract] [Full Text] [Related]
5. Inhaled corticosteroids--their present and future role in the management of asthma.
König P
J Allergy Clin Immunol; 1988 Aug; 82(2):297-306. PubMed ID: 3042840
[No Abstract] [Full Text] [Related]
6. [Corticosteroid therapy].
Reinhart WH
Praxis (Bern 1994); 2005 Feb; 94(7):239-43. PubMed ID: 15773140
[TBL] [Abstract][Full Text] [Related]
7. Reducing the problems of corticosteroid therapy.
Lessof MH
Br J Hosp Med; 1977 Oct; 18(4):360-3, 365. PubMed ID: 199305
[No Abstract] [Full Text] [Related]
8. Inhaled corticosteroids: 2. Systemic toxicity.
Samraj GP; Kuritzky L
Hosp Pract (1995); 2000 Jun; 35(6):35-8. PubMed ID: 10884817
[No Abstract] [Full Text] [Related]
9. Oral vs parenteral corticosteroids: a clinical controversy.
Rees RB
J Am Acad Dermatol; 1981 Nov; 5(5):602-4. PubMed ID: 7298927
[No Abstract] [Full Text] [Related]
10. Nephrotoxicities of antineoplastic and immunosuppressive agents.
Raymond JR
Curr Probl Cancer; 1984 Oct; 8(16):1-32. PubMed ID: 6238806
[No Abstract] [Full Text] [Related]
11. Inhaled corticosteroids: benefits and risks.
Robinson DS; Geddes DM
J Asthma; 1996; 33(1):5-16. PubMed ID: 8621371
[No Abstract] [Full Text] [Related]
12. Topical steroids and hypothalamo-pituitary-adrenal suppression: a review.
Bartley PC
Australas J Dermatol; 1978 Dec; 19(3):109-13. PubMed ID: 371599
[No Abstract] [Full Text] [Related]
13. [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al].
Hohlfeld R; Engelhardt D
Nervenarzt; 1994 Feb; 65(2):148. PubMed ID: 8164771
[No Abstract] [Full Text] [Related]
14. [Corticosteroid treatment and adrenal regulatory system].
Goischke HK
ZFA (Stuttgart); 1978 Aug; 54(22):1129-33. PubMed ID: 685408
[No Abstract] [Full Text] [Related]
15. [Corticosteroid therapy].
Pentikäinen PJ
Duodecim; 1986; 102(22):1690-9. PubMed ID: 3803259
[No Abstract] [Full Text] [Related]
16. Adrenal suppression after short-term corticosteroid therapy.
Wilson KS; Parker AC
Lancet; 1979 May; 1(8124):1030. PubMed ID: 86742
[No Abstract] [Full Text] [Related]
17. Cushing's Syndrome in a 6-month-old Boy: A Rare Side-effect due to Inadequate use of Topical Corticosteroids.
Ciccone S; Marini R; Bizzarri C; El Hachem M; Cappa M
Acta Derm Venereol; 2016 Jan; 96(1):138-9. PubMed ID: 26038976
[No Abstract] [Full Text] [Related]
18. Effects of oral and inhaled corticosteroids on the hypothalamic-pituitary-adrenal axis.
Lipworth BJ; Jackson CM
J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):713-4. PubMed ID: 10482856
[No Abstract] [Full Text] [Related]
19. Locally administered ocular corticosteroids: benefits and risks.
McGhee CN; Dean S; Danesh-Meyer H
Drug Saf; 2002; 25(1):33-55. PubMed ID: 11820911
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of inhaled corticosteroids (ICS) in children with asthma.
Petrisko MA; Skoner JD; Skoner DP
J Asthma; 2008; 45 Suppl 1():1-9. PubMed ID: 19093279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
